A promyelocytic leukemia protein-thrombospondin 2 axis and the risk of relapse in neuroblastoma

This work was in part funded by a Wellcome Trust project grant (to P. Salomoni and A. Sala). P. Salomoni is funded by the Brain Tumor Charity, the NIHR UCL Biomedical Research Centre among other funding bodies. A. Pistorio and V. Pistoia were supported by funds "Cinque per mille" and "Ricerca corrente" fromthe Italian Health Ministry to the Istituto Gaslini.